We examined their accuracies in discriminating cognitive stage (MCI/AD vs. SCD) and preclinical Aβ status (SCD Aβ-positive vs. SCD Aβ-negative), their associations with cross-sectional and longitudinal cognition, their longitudinal changes over time, and longitudinal tau biomarker relationships with longitudinal cognition. Here, MAPT is linked to Alzheimer disease.